Versi LLC
Records under this name other than the patents Versi LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 3 patents it holds.
Showing 1 to 10 of 10 · Back to Versi LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,071,093 | Method of Treating Parkinson's Disease with a Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity Term ended Term ended Sep 5, 2026 · High confidence | Term ended | Term ended Sep 5, 2026 | High confidence |
| US 11,246,865 | Opioid for use to reduce and/or treat drug addiction Lapsed on the fee record Ended Feb 15, 2026 · From the USPTO record | Lapsed on the fee record | Ended Feb 15, 2026 | From the USPTO record |
| US 8,642,599 | Method of Treating Parkinson's Disease with Diarylmethylpiperazine Compounds Exhibiting Delta Receptor Agonist Activity Lapsed on the fee record Ended Feb 4, 2026 · High confidence | Lapsed on the fee record | Ended Feb 4, 2026 | High confidence |
| US 9,701,645 | Method of Treating Parkinson's Disease with a Diarylmethylpiperazine Compounds Exhibiting Delta Opioid Receptor Agonist Activity Lapsed on the fee record Ended Jul 11, 2025 · High confidence | Lapsed on the fee record | Ended Jul 11, 2025 | High confidence |
| US 8,865,721 | Delta opioid receptor agonist compounds Lapsed on the fee record Ended Oct 21, 2022 · From the USPTO record | Lapsed on the fee record | Ended Oct 21, 2022 | From the USPTO record |
| US 8,575,169 | Method of treating sexual dysfunctions with delta opioid receptor agonist compounds Lapsed on the fee record Ended Nov 5, 2021 · From the USPTO record | Lapsed on the fee record | Ended Nov 5, 2021 | From the USPTO record |
| US 8,551,998 | Delta opioid receptor agonist compounds Lapsed on the fee record Ended Oct 8, 2021 · From the USPTO record | Lapsed on the fee record | Ended Oct 8, 2021 | From the USPTO record |
| US 8,476,280 | Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists Lapsed on the fee record Ended Jul 2, 2021 · From the USPTO record | Lapsed on the fee record | Ended Jul 2, 2021 | From the USPTO record |
| US 9,296,707 | Delta opioid receptor agonist compounds Lapsed on the fee record Ended Mar 29, 2020 · From the USPTO record | Lapsed on the fee record | Ended Mar 29, 2020 | From the USPTO record |
| US 5,262,103 | Cold molding process Term ended Term ended no later than Nov 16, 2013 · Low confidence | Term ended | Term ended no later than Nov 16, 2013 | Low confidence |